Report Detail
Global Perphenazine Market Growth 2019-2024
- RnM2895338 |
- 07 February, 2019 |
- Global |
- 138 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global average price of Perphenazine is in the decreasing trend, from 6.95 USD/Unit in 2012 to 7.08 USD/Unit in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Perphenazine includes Oral Forms and Injectable Solution, and the proportion of Oral Forms in 2016 is about 98%.
Perphenazine is widely used to treat psychosis and antiemetic. The most proportion of Perphenazine is used to treat psychosis, and the proportion in 2016 is 95%.
North America is the largest consumption place, with a consumption market share nearly 39% in 2015. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Market competition is not intense. Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Perphenazine market will register a 0.7% CAGR in terms of revenue, the global market size will reach US$ 100 million by 2024, from US$ 95 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Perphenazine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Perphenazine market by product type, application, key manufacturers and key regions and countries.
This study considers the Perphenazine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Oral Forms
Injectable Solution
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Psychosis
Antiemetic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Perphenazine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Perphenazine market by identifying its various subsegments.
Focuses on the key global Perphenazine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Perphenazine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Perphenazine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Perphenazine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Perphenazine Consumption 2014-2024
- 2.1.2 Perphenazine Consumption CAGR by Region
- 2.2 Perphenazine Segment by Type
- 2.2.1 Oral Forms
- 2.2.2 Injectable Solution
- 2.3 Perphenazine Consumption by Type
- 2.3.1 Global Perphenazine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Perphenazine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Perphenazine Sale Price by Type (2014-2019)
- 2.4 Perphenazine Segment by Application
- 2.4.1 Psychosis
- 2.4.2 Antiemetic
- 2.5 Perphenazine Consumption by Application
- 2.5.1 Global Perphenazine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Perphenazine Value and Market Share by Application (2014-2019)
- 2.5.3 Global Perphenazine Sale Price by Application (2014-2019)
3 Global Perphenazine by Players
- 3.1 Global Perphenazine Sales Market Share by Players
- 3.1.1 Global Perphenazine Sales by Players (2017-2019)
- 3.1.2 Global Perphenazine Sales Market Share by Players (2017-2019)
- 3.2 Global Perphenazine Revenue Market Share by Players
- 3.2.1 Global Perphenazine Revenue by Players (2017-2019)
- 3.2.2 Global Perphenazine Revenue Market Share by Players (2017-2019)
- 3.3 Global Perphenazine Sale Price by Players
- 3.4 Global Perphenazine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Perphenazine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Perphenazine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Perphenazine by Regions
- 4.1 Perphenazine by Regions
- 4.1.1 Global Perphenazine Consumption by Regions
- 4.1.2 Global Perphenazine Value by Regions
- 4.2 Americas Perphenazine Consumption Growth
- 4.3 APAC Perphenazine Consumption Growth
- 4.4 Europe Perphenazine Consumption Growth
- 4.5 Middle East & Africa Perphenazine Consumption Growth
5 Americas
- 5.1 Americas Perphenazine Consumption by Countries
- 5.1.1 Americas Perphenazine Consumption by Countries (2014-2019)
- 5.1.2 Americas Perphenazine Value by Countries (2014-2019)
- 5.2 Americas Perphenazine Consumption by Type
- 5.3 Americas Perphenazine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Perphenazine Consumption by Countries
- 6.1.1 APAC Perphenazine Consumption by Countries (2014-2019)
- 6.1.2 APAC Perphenazine Value by Countries (2014-2019)
- 6.2 APAC Perphenazine Consumption by Type
- 6.3 APAC Perphenazine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Perphenazine by Countries
- 7.1.1 Europe Perphenazine Consumption by Countries (2014-2019)
- 7.1.2 Europe Perphenazine Value by Countries (2014-2019)
- 7.2 Europe Perphenazine Consumption by Type
- 7.3 Europe Perphenazine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Perphenazine by Countries
- 8.1.1 Middle East & Africa Perphenazine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Perphenazine Value by Countries (2014-2019)
- 8.2 Middle East & Africa Perphenazine Consumption by Type
- 8.3 Middle East & Africa Perphenazine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Perphenazine Distributors
- 10.3 Perphenazine Customer
11 Global Perphenazine Market Forecast
- 11.1 Global Perphenazine Consumption Forecast (2019-2024)
- 11.2 Global Perphenazine Forecast by Regions
- 11.2.1 Global Perphenazine Forecast by Regions (2019-2024)
- 11.2.2 Global Perphenazine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Perphenazine Forecast by Type
- 11.8 Global Perphenazine Forecast by Application
12 Key Players Analysis
- 12.1 Teva
- 12.1.1 Company Details
- 12.1.2 Perphenazine Product Offered
- 12.1.3 Teva Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Teva News
- 12.2 Sandoz
- 12.2.1 Company Details
- 12.2.2 Perphenazine Product Offered
- 12.2.3 Sandoz Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sandoz News
- 12.3 Endo
- 12.3.1 Company Details
- 12.3.2 Perphenazine Product Offered
- 12.3.3 Endo Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Endo News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Perphenazine Product Offered
- 12.4.3 Mylan Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
- 12.5 ZHPHARMA
- 12.5.1 Company Details
- 12.5.2 Perphenazine Product Offered
- 12.5.3 ZHPHARMA Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 ZHPHARMA News
- 12.6 Shandong Boshan Pharma
- 12.6.1 Company Details
- 12.6.2 Perphenazine Product Offered
- 12.6.3 Shandong Boshan Pharma Perphenazine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Shandong Boshan Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Perphenazine . Industry analysis & Market Report on Perphenazine is a syndicated market report, published as Global Perphenazine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Perphenazine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
